When pain lingers for more than two weeks and won’t go away with medication, that’s a big red flag, says our Dr. Pamela Soliman.

Learn about ovarian cancer pain and when to see your doctor: brnw.ch/21wILUm Pamela T. Soliman MD #EndCancer

One of the most impactful talks I have heard on any topic. Glad you saw it!

👏👏👏Congratulations to Naomi Adjei, MD, MPH, MSEd who knocked it out of the park presenting on opportunistic salpingectomy at the #SGOMtg . Our MD Anderson Cancer Center fellows are working to #endcancer #gyncsm Larissa Meyer

🤔Analysis of the GOG258 trial results in #EndometrialCancer based on TCGA classifiers is intriguing...
Improvement in RFS for p53wt treated with chemoradiation as opposed to chemotherapy, however, no apparent benefit w/ radiation therapy in MMRd #SGOMtg #gyncsm #radonc

Your legacy is for life! Thank you for making room for all of us! Your bravery, vulnerability and generosity have inspired me. Thank you Dr. Frumovitz MD Anderson Cancer Center SGO #SGO2024

Congrats to our fellow Dr Huepenbecker on her poster presentation SGO evaluating outcomes of traditional ERAS pathways in patients undergoing pelvic exenteration in Gyn cancers MD Anderson Cancer Center #SGOMtg #gyncsm #oncsurgery

We really have the best fellows! All 12 of them!! MD Anderson Cancer Center #gynonc

Congrats ⁦Jharna M. Patel, MD⁩ & Dr. Marina Stasenko on use of #chatGpT in #geneticcounseling in #gynonc ! #sgo2024 #PowerofSharedPurpose ⁦SGO⁩ ⁦The GOG Foundation Inc.⁩ ⁦NRG Oncology⁩ ⁦IGCS⁩ ⁦ASCO⁩ ⁦Perlmutter Cancer Center at NYU Langone Health⁩ ⁦ACOG⁩ ⁦GYN Cancer | #GYNCSM⁩

Exciting work by Dr Asare and Anil Sood MD Anderson Cancer Center using deep learning models and AI to evaluate tumor morphology and outcomes in #ovariancancer #SGOMtg #gyncsm #oncsurgery

Ovarian cancer is deadly, costly, and impacts overall QOL. Primary prevention via opportunistic salpingectomy is cost-effective and safe. Thanks to my mentors and SGO for the opportunity to discuss our work. #SGO2024 📸Dana Hazimeh

Incredibly proud of my ⭐️ co-fellow Amma Asare for presenting her research on factors associated with therapy related myeloid neoplasms (t-MN) in patients with ovarian cancer treated with PARP inhibitors. We must balance risks and benefits of PARPi ⚖️ MD Anderson Cancer Center Anil Sood

Excellent work by Dr Asare and Anil Sood MD Anderson Cancer Center evaluating risk factors of MDS in #ovariancancer patients receiving PARPi therapy #SGOMtg #gyncsm #oncsurgery

So proud of Dr Reem Saab for her presentation on hormonal options in low grade endometrial stromal #sarcoma #endcancer MD Anderson Cancer Center #SGOMtg #powerofsharedpurpose Nicole D. Fleming MD Larissa Meyer

Felix Rutledge alumni dinner MD Anderson Cancer Center & more alumni SGO #SGOMtg #PowerofSharedPurpose
Karen Lu Pamela T. Soliman MD Shannon Westin, MD, MPH, FASCO Larissa Meyer Lauren Cobb, MD Marilyn Huang Aaron Shafer Anne Knisely, MD Katie Kurnit Han T. Cun Katherine Ikard Stewart
Kiran Clair Gorge Orwell 🚶🏻‍♀️🦆🚶🏻‍♀️🦆

Congratulations to Anne Knisely, MD Amir Jazaeri MD Anderson Cancer Center on this impactful work evaluating prognostic markers of MRD and ctDNA in #ovariancancer #SGOMtg #oncsurgery

Great presentation by Dr Fernandez MD Anderson Cancer Center SGO on tumor microenvironment in obese patients with #endometrialcancer #SGOMtg

“Most of the FDA-approved treatments for neuroendocrine tumors were tested at MD Anderson through clinical trials,” says our Dr. Daniel Halperin.
Here, he shares what to know about neuroendocrine tumors, including the latest treatment advances: brnw.ch/21wHy3m #EndCancer

Last week, incoming SGO President Amanda Nickles Fader, MD attended in-person meetings with Congressional offices to discuss chemotherapy drug shortages and appropriations requests that include funding for ovarian and endometrial cancer research.

We are incredibly honored to have Diane Yamada as our annual Wharton lectureship MD Anderson Cancer Center Truly visionary leader, mentor and sponsor in Gyn Oncology! 👏🏻 #oncsurgery

Dr. Rauh-Hain is an ACS grantee, researcher and gynecologic oncologist at MD Anderson Cancer Center. Learn how the grant will help him work towards increasing cancer screening rates, especially hereditary breast & ovarian cancer. Learn about getting screened: amercancer.co/DrHain